Vulnerability in Oracle Life Sciences Central Designer

CVE-2026-21970

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).

Published · last modified .

CVSS v3 metric

CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N.

EPSS exploit prediction

EPSS: 0.003 (19.1th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 19th percentile — 19.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2026-21970: held from 0.003 to 0.003.

EPSS over last 30 days · oldest: 0.003 · newest: 0.003 · change: +0.000

Affected products

References

Frequently asked questions

What is CVE-2026-21970?
CVE-2026-21970 is a medium-severity vulnerability in Oracle Life Sciences Central Designer. CVSS score: 6.5/10. Published 2026-01-20.
How severe is CVE-2026-21970?
Medium severity. CVSS v3 base score is 6.5 out of 10.